HK Stock MarketDetailed Quotes

09996 PEIJIA-B

Watchlist
  • 4.030
  • -0.040-0.98%
Not Open Dec 12 16:08 CST
2.69BMarket Cap-9.76P/E (TTM)

PEIJIA-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
33.94%301.2M
75.86%441.13M
89.29%224.87M
83.71%250.83M
129.83%118.8M
253.21%136.53M
263.01%51.69M
106.72%38.66M
--14.24M
--18.7M
Operating income
33.94%301.2M
75.86%441.13M
89.29%224.87M
83.71%250.83M
129.83%118.8M
253.21%136.53M
263.01%51.69M
106.72%38.66M
14.24M
18.7M
Cost of sales
-58.60%-82.34M
-55.10%-115.76M
-45.84%-51.91M
-82.56%-74.63M
-149.12%-35.6M
-204.35%-40.88M
-170.37%-14.29M
-100.90%-13.43M
---5.29M
---6.69M
Operating expenses
-58.60%-82.34M
-55.10%-115.76M
-45.84%-51.91M
-82.56%-74.63M
-149.12%-35.6M
-204.35%-40.88M
-170.37%-14.29M
-100.90%-13.43M
-5.29M
-6.69M
Gross profit
26.54%218.87M
84.66%325.37M
107.88%172.96M
84.21%176.2M
122.47%83.2M
279.23%95.65M
317.69%37.4M
109.96%25.22M
8.95M
12.01M
Selling expenses
11.93%-151.57M
-34.50%-324.98M
-85.71%-172.09M
-159.12%-241.63M
-327.46%-92.67M
-341.41%-93.25M
-319.97%-21.68M
-182.36%-21.13M
---5.16M
---7.48M
Administrative expenses
-0.39%-62.63M
-14.75%-141.64M
-4.65%-62.38M
-7.87%-123.43M
-12.30%-59.61M
3.01%-114.43M
18.74%-53.08M
31.95%-117.97M
---65.33M
-279.52%-173.37M
Research and development expenses
41.34%-100.48M
21.36%-293.42M
-105.32%-171.3M
16.32%-373.13M
36.46%-83.43M
-331.36%-445.88M
-218.95%-131.29M
-87.48%-103.37M
---41.16M
-97.96%-55.13M
Special items of operating profit
2,338.34%11.04M
-96.73%3.91M
-101.13%-493K
392.04%119.44M
328.33%43.75M
78.07%-40.9M
-538.59%-19.16M
-6,214.83%-186.48M
--4.37M
-189.24%-2.95M
Operating profit
63.66%-84.77M
2.66%-430.76M
-114.53%-233.31M
26.09%-442.55M
42.10%-108.75M
-48.32%-598.8M
-91.01%-187.81M
-77.91%-403.72M
-98.33M
-223.15%-226.92M
Financing income
-25.21%16.43M
-15.42%39.44M
21.49%21.97M
88.24%46.63M
39.29%18.08M
-26.29%24.77M
64.14%12.98M
752.03%33.6M
--7.91M
1,557.14%3.94M
Financing cost
-0.76%-132K
92.31%-178K
88.31%-131K
-1,145.16%-2.32M
-229.71%-1.12M
99.19%-186K
98.52%-340K
-2,696.72%-23.02M
---22.98M
82.84%-823K
Special items of earning before tax
----
----
----
----
----
----
----
-443.69%-1.68B
---1.68B
-3,706.98%-308.18M
Earning before tax
67.62%-68.48M
1.69%-391.5M
-130.38%-211.47M
30.65%-398.24M
47.60%-91.79M
72.24%-574.22M
90.21%-175.17M
-288.86%-2.07B
-1.79B
-541.90%-531.98M
Tax
-365.78%-2.8M
89.01%-1.05M
-213.54%-602K
---9.57M
---192K
----
----
----
----
----
After-tax profit from continuing operations
66.39%-71.28M
3.74%-392.55M
-130.55%-212.08M
28.98%-407.81M
47.49%-91.99M
72.24%-574.22M
90.21%-175.17M
-288.86%-2.07B
-1.79B
-541.90%-531.98M
Earning after tax
66.39%-71.28M
3.74%-392.55M
-130.55%-212.08M
28.98%-407.81M
47.49%-91.99M
72.24%-574.22M
90.21%-175.17M
-288.86%-2.07B
-1.79B
-541.90%-531.98M
Minority profit
28.57%-10K
---28K
---14K
----
----
----
----
----
----
----
Profit attributable to shareholders
66.39%-71.27M
3.75%-392.53M
-130.54%-212.06M
28.98%-407.81M
47.49%-91.99M
72.24%-574.22M
90.21%-175.17M
-288.86%-2.07B
-1.79B
-543.85%-531.98M
Basic earnings per share
67.74%-0.1
4.92%-0.58
-121.43%-0.31
29.07%-0.61
48.15%-0.14
80.59%-0.86
96.89%-0.27
-90.13%-4.43
-8.68
74.25%-2.33
Diluted earnings per share
67.74%-0.1
4.92%-0.58
-121.43%-0.31
29.07%-0.61
48.15%-0.14
80.59%-0.86
96.89%-0.27
-90.13%-4.43
-8.68
74.25%-2.33
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Turnover 33.94%301.2M75.86%441.13M89.29%224.87M83.71%250.83M129.83%118.8M253.21%136.53M263.01%51.69M106.72%38.66M--14.24M--18.7M
Operating income 33.94%301.2M75.86%441.13M89.29%224.87M83.71%250.83M129.83%118.8M253.21%136.53M263.01%51.69M106.72%38.66M14.24M18.7M
Cost of sales -58.60%-82.34M-55.10%-115.76M-45.84%-51.91M-82.56%-74.63M-149.12%-35.6M-204.35%-40.88M-170.37%-14.29M-100.90%-13.43M---5.29M---6.69M
Operating expenses -58.60%-82.34M-55.10%-115.76M-45.84%-51.91M-82.56%-74.63M-149.12%-35.6M-204.35%-40.88M-170.37%-14.29M-100.90%-13.43M-5.29M-6.69M
Gross profit 26.54%218.87M84.66%325.37M107.88%172.96M84.21%176.2M122.47%83.2M279.23%95.65M317.69%37.4M109.96%25.22M8.95M12.01M
Selling expenses 11.93%-151.57M-34.50%-324.98M-85.71%-172.09M-159.12%-241.63M-327.46%-92.67M-341.41%-93.25M-319.97%-21.68M-182.36%-21.13M---5.16M---7.48M
Administrative expenses -0.39%-62.63M-14.75%-141.64M-4.65%-62.38M-7.87%-123.43M-12.30%-59.61M3.01%-114.43M18.74%-53.08M31.95%-117.97M---65.33M-279.52%-173.37M
Research and development expenses 41.34%-100.48M21.36%-293.42M-105.32%-171.3M16.32%-373.13M36.46%-83.43M-331.36%-445.88M-218.95%-131.29M-87.48%-103.37M---41.16M-97.96%-55.13M
Special items of operating profit 2,338.34%11.04M-96.73%3.91M-101.13%-493K392.04%119.44M328.33%43.75M78.07%-40.9M-538.59%-19.16M-6,214.83%-186.48M--4.37M-189.24%-2.95M
Operating profit 63.66%-84.77M2.66%-430.76M-114.53%-233.31M26.09%-442.55M42.10%-108.75M-48.32%-598.8M-91.01%-187.81M-77.91%-403.72M-98.33M-223.15%-226.92M
Financing income -25.21%16.43M-15.42%39.44M21.49%21.97M88.24%46.63M39.29%18.08M-26.29%24.77M64.14%12.98M752.03%33.6M--7.91M1,557.14%3.94M
Financing cost -0.76%-132K92.31%-178K88.31%-131K-1,145.16%-2.32M-229.71%-1.12M99.19%-186K98.52%-340K-2,696.72%-23.02M---22.98M82.84%-823K
Special items of earning before tax -----------------------------443.69%-1.68B---1.68B-3,706.98%-308.18M
Earning before tax 67.62%-68.48M1.69%-391.5M-130.38%-211.47M30.65%-398.24M47.60%-91.79M72.24%-574.22M90.21%-175.17M-288.86%-2.07B-1.79B-541.90%-531.98M
Tax -365.78%-2.8M89.01%-1.05M-213.54%-602K---9.57M---192K--------------------
After-tax profit from continuing operations 66.39%-71.28M3.74%-392.55M-130.55%-212.08M28.98%-407.81M47.49%-91.99M72.24%-574.22M90.21%-175.17M-288.86%-2.07B-1.79B-541.90%-531.98M
Earning after tax 66.39%-71.28M3.74%-392.55M-130.55%-212.08M28.98%-407.81M47.49%-91.99M72.24%-574.22M90.21%-175.17M-288.86%-2.07B-1.79B-541.90%-531.98M
Minority profit 28.57%-10K---28K---14K----------------------------
Profit attributable to shareholders 66.39%-71.27M3.75%-392.53M-130.54%-212.06M28.98%-407.81M47.49%-91.99M72.24%-574.22M90.21%-175.17M-288.86%-2.07B-1.79B-543.85%-531.98M
Basic earnings per share 67.74%-0.14.92%-0.58-121.43%-0.3129.07%-0.6148.15%-0.1480.59%-0.8696.89%-0.27-90.13%-4.43-8.6874.25%-2.33
Diluted earnings per share 67.74%-0.14.92%-0.58-121.43%-0.3129.07%-0.6148.15%-0.1480.59%-0.8696.89%-0.27-90.13%-4.43-8.6874.25%-2.33
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday-0.85%